Argenx
ARGX
#534
Rank
HK$296.38 B
Marketcap
HK$4,847
Share price
-0.35%
Change (1 day)
75.26%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : HK$4.15 Billion

According to Argenx 's latest financial reports the company's total liabilities are HK$4.15 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Argenx - Total liabilities on balance sheet (from 2021 to 2020)

Total liabilities by year

Year Total liabilities Change
2022-12-31HK$2.50 B1.63%
2021-12-31HK$2.46 B-57.3%
2020-12-31HK$5.77 B53.93%
2019-12-31HK$3.74 B813.36%
2018-12-31HK$0.41 B40.53%
2017-12-31HK$0.29 B-19.67%
2016-12-31HK$0.36 B352.03%
2015-12-31HK$80.45 M-16.78%
2014-12-31HK$96.67 M97.64%
2013-12-31HK$48.91 M-24%
2012-12-31HK$64.36 M57.86%
2011-12-31HK$40.77 M94.15%
2010-12-31HK$21 M